Ads
related to: lung cancer, study- Education Resources
Learning Materials & Guidance
For Patients, Families & Caregivers
- Doctors & Locations
Over 200 Medical, Radiation &
Surgical Oncologists. Search Now.
- Patient Resources
What to Expect: Your Treatment
Your Feelings. Your Care.
- Awards & Recognition
We Are Consistently Recognized for
Our High Standards of Cancer Care.
- Clinical Trials
UPMC Hillman Cancer Center
Pioneering New Cancer Treatments
- Hillman is Here for You
Understand Your Cancer Diagnosis
& Care Options. Speak to an Expert.
- Education Resources
Search results
Lung cancer treatment produces progression-free survival results in Phase III trial
Medical Xpress· 2 hours agoIn a recent study led by Suresh Ramalingam, MD, executive director of Winship Cancer Institute of Emory University, a new drug has shown remarkable promise ...
Pfizer drug extends life for patients with rare lung cancer usually seen in nonsmokers
NBC Universal via AOL· 5 days agoPfizer’s lung cancer drug Lorbrena can extend life for patients with a rare form of the disease for...
New lung cancer pill could ‘stop disease in its tracks’
Daily Telegraph· 5 days agoPatients with an incurable form of lung cancer could lead normal lives by taking a daily pill that...
Lung Cancer Was a Death Sentence. Now Drugs Are Saving Lives.
The Wall Street Journal· 3 days agoMore patients can fend off the disease for months or years with targeted or immune-boosting drugs,...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga via Yahoo Finance· 22 hours agoOn Friday, Pfizer Inc (NYSE: PFE) revealed its drug for an advanced form of lung cancer showed...
Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data
FOX Business· 5 days agoPfizer said it expects its cancer drug Lorbrena to top $1 billion in annual sales by 2030 on the...
Lung cancer wonder drug hailed as study shows 'off the chart' survival benefit
Daily Express· 5 days agoResults from a trial of daily pill lorlatinib were described as "unprecedented".
Newswise Expert | Narjust Florez, Dana-Farber Cancer Institute
Newswise· 12 hours agoDr. Narjust Florez is the Associate Director of the Cancer Care Equity Program and a thoracic medical oncologist at the Dana-Farber Brigham Cancer Center ...
Summit Shares Soar After Lung Cancer Drug Tops Keytruda in Study
Bloomberg· 6 days agoSummit Therapeutics Inc. shares jumped after the biotech company said a late-stage trial met its...
Landmark Blood-Based AI Lung Cancer Screening Test Study Results Published in Cancer Discovery
Tehachapi News· 2 days agoThe report details the performance and potential of DELFI's FirstLook Lung test. This milestone study, led by top researchers in the field, marks a significant ...
Ads
related to: lung cancer, study